Patient Home Monitoring Corp. Executes LOI to Acquire A $14 Million Annual Revenue Company

Life Science Investing News

Patient Home Monitoring Corp. (TSXV:PHM) executed a non-binding Letter of Intent for the acquisition of a $14 million annual revenue company servicing patients with chronic pulmonary illnesses.

Patient Home Monitoring Corp. (TSXV:PHM) executed a non-binding Letter of Intent for the acquisition of a $14 million annual revenue company servicing patients with chronic pulmonary illnesses.

As quoted in the press release:

The purchase price is proposed to be less than 3.2 times 12-month Adjusted EBITDA. The acquisition of this growing and profitable company is expected be immediately accretive to the income statement and will substantially increase PHM’s earnings-per-share (EPS). As a result of this acquisition, PHM’s annual revenue run rate is expected to be over $28,000,000.

Click here to read the Patient Home Monitoring Corp. (TSXV:PHM) press release

See this press release on Marketwire

The Conversation (0)
×